Anavo Therapeutics

Developer of drugs for cancer treatment

placeLeiden, South Holland, Netherlands calendar_todayFounded 2020 groups10 employees language anavotx.com

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 166 times.

YearFilings
20251
20262

Social engagement

Social engagement: 2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include MRLV, M Ventures, Inkef, Taiho Ventures.

Investor typeCountShare
Venture capital5100%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

29 Jun 2026 · Senior/Principal Cell Biologist · Heidelberg BioLabs

Based on job postings tracked across public sources.

Recent activity

10 Jun 2026
Event
biocap Europe 2026
3 Jun 2026
Event
bio:cap Europe 2026
27 Feb 2026
Event
19th Annual European Life Sciences CEO Forum (#Sachs_ELSF)
Coming soon